07 Jan 2001

Anginovag aerosol - España

Updated: 07 Jan 2001

Anginovag aerosol 20 ml

Prevención y tratamiento de afecciones bucofaríngeas: alivia la disfagia y el dolor de garganta.

Anginovag aerosol Description, Presentation and Dosage

Anginovag aerosol Description

Anginovag aerosol Drug Class Description

Antiinfecciosos faringeos de accion topica inc. anestesicos

Anginovag aerosol Drug Description

SPRAY-AEROSOL

Anginovag aerosol Presentation

Anginovag aerosol Presentation

Adultos: Dosis inicial: 1 nebulización cada 2-3 horas. Dosis de mantenimiento: 1 nebulización cada 6 horas.

Anginovag aerosol Manufacturer

NOVAG

Related Learning Zones

Obesity CME series

Obesity CME series

This European Obesity Initiative CME series contains three online modules, which are ideal for healthcare professionals looking to widen their understanding of obesity as a serious medical illness. Each module is EACCME-accredited and free to complete. Successful completion of the series will earn participants a combined total of 5 European CME credits (ECMECs).

Type 2 Diabetes

Type 2 Diabetes

The Type 2 Diabetes Learning Zone comprises the Type 2 Diabetes Mellitus Knowledge Centre containing current epidemiology statistics, current diagnosis criteria from WHO and ADA, treatment options and latest guidelines; a Therapy Focus area compiling material on emerging insulin/incretin treatment combinations; and two free CME activities, which are the EACCME-accredited ‘Role of Newer Therapies for Type 2 Diabetes in Combination with Insulin’ (worth 1 CME credit) and ‘Best Practice in Type 2 Diabetes: Update on Incretin Therapies in Combination with Insulin’. 

Anginovag aerosol Dosage

Anginovag aerosol Precautions, Reactions and Contraindications

Anginovag aerosol Special Precautions

Anginovag aerosol Adverse Reactions

Anginovag aerosol Adverse Reactions

Irritación de garganta, ronquera, tos, ocasionalmente.

Related Drugs - Otorrinolaringología

Back to top